PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
14-Feb-2024 U.S. Food and Drug Administration Accepts for Priority Review Bristol Myers Squibb’s Application for Augtyro™ (repotrectinib) for the Treatment of Patients with NTRK-Positive Locally Advanced or Metastatic Solid Tumors Businesswire
14-Feb-2024 CORRECTING and REPLACING, Galderma Announces Regulatory Filing Acceptance for Nemolizumab in Prurigo Nodularis and Atopic Dermatitis in the U.S. and EU Businesswire
14-Feb-2024 United Therapeutics Corporation to Report Fourth Quarter and Full Year 2023 Financial Results Before the Market Opens on Wednesday, February 21, 2024 Businesswire
14-Feb-2024 The Sustained Power of Aplantex’s Strategic Game Plan Is Confirmed by the Securing of $ 3.3 M in Second-Round Financing Businesswire
14-Feb-2024 Freudenberg Medical establishes second production facility in Costa Rica Businesswire
14-Feb-2024 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
14-Feb-2024 Medscape Global Launches Innovative Programmatic Offering Setting a New Standard in Targeted HCP Engagement in the United Kingdom, European Union and Canada Businesswire
14-Feb-2024 uMed helps Queen Mary University of London and University College London move closer to understanding Parkinson’s risk factors as first-of-its-kind study exceeds 10,000 participant milestone uMed
14-Feb-2024 Galderma Announces Regulatory Filing Acceptance for Nemolizumab in Prurigo Nodularis and Atopic Dermatitis in the U.S. and EU Businesswire
14-Feb-2024 Immunome Announces Pricing of Public Offering of Common Stock Businesswire
14-Feb-2024 Lost Money in Amylyx Pharmaceuticals, Inc.? Gibbs Law Group Investigates Potential Securities Law Violations Businesswire
14-Feb-2024 Treadwell Announces the Formation and Members of Scientific Advisory Board Businesswire
14-Feb-2024 MEI Pharma Reports Second Quarter Fiscal Year 2024 Results and Operational Highlights Businesswire
14-Feb-2024 Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of Amylyx Pharmaceuticals, Inc. (AMLX) Investors Businesswire
14-Feb-2024 Vistagen Reports Fiscal 2024 Third Quarter Financial Results and Provides Corporate Update Businesswire
14-Feb-2024 Electromed, Inc. Announces Record Financial Performance in Fiscal 2024 Second Quarter Businesswire
14-Feb-2024 Immunome Announces Proposed Public Offering of Common Stock Businesswire
14-Feb-2024 Ligand to Report Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024 Businesswire
13-Feb-2024 Nature Made® Introduces Advanced Multivitamin Gummies with a Unique Combination of 20 Essential Nutrients to Help Consumers Get the Daily Nutritional Support They Need Businesswire
13-Feb-2024 Areteia Therapeutics kündigt weitere 75 Millionen US-Dollar in Serie A-Finanzierung für orales Dexpramipexol bei eosinophilem Asthma an Businesswire